ORGO FY 2019 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$338M

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$261M+34.9% YoY

Gross Profit

$185M70.9% margin

Operating Income

-$30M-11.4% margin

Net Income

-$39M-14.8% margin

EPS (Diluted)

$-0.44

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$40M

Stock-Based Comp.

$936,000

Balance Sheet

Total Assets

$221M

Total Liabilities

$165M

Stockholders' Equity

$56M

Cash & Equivalents

$60M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$261M	$193M	+34.9%
Gross Profit	$185M	$125M	+48.5%
Operating Income	-$30M	-$52M	+42.1%
Net Income	-$39M	-$65M	+40.3%